Silicone Based Catheters Market ($240.9Mn by 2028) Growth Forecast at 6.9% CAGR During 2021 to 2028 COVID Impact and Global Analysis by The Insight Partners
March 30, 2022 13:28 ET
|
The Insight Partners
New York, March 30, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Silicone Based Catheters Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...
Global Urinary Tract Infection Therapeutics Market Size Will Touch USD 11,652 Million Mark by 2027, at a 4.56% CAGR: Study by Facts & Factors
February 02, 2022 10:01 ET
|
Facts & Factors
NEW YORK, United States, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Urinary Tract Infection Therapeutics Market- By Age Group (Children, Adults...
MicroGenDX First Independent Commercial Lab in US Offering NGS for Infections to Appeal Directly to Patients
January 24, 2022 18:07 ET
|
Microgen Diagnostics
ORLANDO, Fla., Jan. 24, 2022 (GLOBE NEWSWIRE) -- Using national TV, radio, and web media campaigns, Microgen Diagnostics will be the first independent commercial lab in the U.S. to appeal directly...
Scripted Launches in Pacific Northwest: Allowing Patients Convenient, Affordable, and Accessible Healthcare at Their Local Pharmacy
October 07, 2021 10:15 ET
|
Scripted
CHICAGO, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Scripted (www.scripted.co) announced its new service to transform healthcare into an on-demand approach, where local pharmacists can prescribe and fill...
ITRM NOTICE: ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED LAW FIRM, Encourages Iterum Therapeutics plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ITRM
August 19, 2021 14:15 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 19, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Iterum Therapeutics plc (NASDAQ: ITRM) between November...
ROSEN, A LONGSTANDING LAW FIRM, Encourages Iterum Therapeutics plc Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline – ITRM
August 11, 2021 19:45 ET
|
The Rosen Law Firm PA
NEW YORK, Aug. 11, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Iterum...
OpGen’s Acuitas® AMR Gene Panel Shows Potential for Reducing Total Time to Targeted Therapy
June 27, 2019 07:30 ET
|
OpGen, Inc.
Collaborator data demonstrating OpGen’s rapid prediction of antibiotic resistance and detection of uropathogens presented at ASM Microbe 2019 GAITHERSBURG, Md., June 27, 2019 (GLOBE NEWSWIRE) --...
OpGen Announces New Data Demonstrating Clinical Utility for Antibiotic Resistant Urinary Tract Infection Patient Management and for Rapid Carbapenem-Resistant Bacteria Outbreak Detection
June 13, 2019 07:30 ET
|
OpGen, Inc.
GAITHERSBURG, Md., June 13, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that data from its Acuitas® AMR Gene Panel and Acuitas Lighthouse® Software will be presented at ASM...
OpGen Completes Initial FDA 510(k) Submission for its Acuitas® AMR Gene Panel Test to Identify Presence of Antibiotic Resistance
May 14, 2019 07:30 ET
|
OpGen, Inc.
GAITHERSBURG, Md., May 14, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN) announced today that it has filed its 510(k) submission with the U.S. Food and Drug Administration (FDA) for clearance...
Cran-Max Effective Prevention in High Risk Cases of UTI
October 23, 2013 15:21 ET
|
Cran-Max
KEARNY, NJ--(Marketwired - Oct 23, 2013) - Urinary tract infections (UTI) are responsible for more than 7 million doctor visits a year. Although UTIs can be treated in the short term with...